Eligibility for the Medicare GLP-1 Bridge will also be limited to Medicare beneficiaries who have not filled a prescription under their Part D plan for a GLP-1 in 2026, and who do not have a diagnosis with a condition that is a medically accepted indication for a GLP-1 drug that could be covered under Part D (specified by CMS as type 2 diabetes, obstructive sleep apnea (OSA), and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)), even if they otherwise meet the clinical criteria
Momtaz S, Hassani S, Khan F, Ziaee M, Abdollahi M
Speedy delivery, great customer service and great product
TB-500 (Thymosin Beta-4) is a naturally occurring healing peptide
Additional adjunctive therapies, including sodium bicarbonate, vitamin B12, or vitamin D, were used in some patients as clinically indicated
& Habener, J